Exodus Point Capital Management, LP Igm Biosciences, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 20,323 shares of IGMS stock, worth $169,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,323
Previous 453,898
95.52%
Holding current value
$169,290
Previous $3.79 Million
94.83%
% of portfolio
0.0%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding IGMS
# of Institutions
90Shares Held
20.5MCall Options Held
11.1KPut Options Held
5.1K-
Baker Bros. Advisors LP New York, NY4.09MShares$34.1 Million0.5% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.89MShares$32.4 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N43.08MShares$25.7 Million1.6% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$25.6 Million1.17% of portfolio
-
Goldman Sachs Group Inc New York, NY1.28MShares$10.7 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $241M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...